List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 19 studies with search of: BI 1356
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Linagliptin
2 Recruiting Safety and Efficacy of BI 1356 Plus Metformin in Type 2 Diabetes, Factorial Design
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Metformin;   Drug: Placebo
3 Active, not recruiting Safety and Efficacy of BI 1356 as Monotherapy or in Combination in Type 2 DM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Pioglitazone
4 Completed BI 1356 in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Placebo
5 Active, not recruiting A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Glimepiride;   Drug: placebo
6 Completed Efficacy and Safety of 3 Doses of BI1356 in Type 2 Diabetes Patients
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356 BI;   Drug: Dose-matched Placebo;   Drug: Open-label metformin
7 Completed Efficacy and Safety of BI 1356 BS in Combination With Metformin in Patients With type2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356 BS;   Drug: Glimepiride
8 Recruiting Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 vs. Placebo, Insulin Background Inclusive
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: placebo
9 Completed Efficacy and Safety of BI 1356 Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: placebo
10 Completed The Effect of BI 1356 on 24h-Glucose Control and Various Biomarkers in Type 2 Diabetic Patients
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: BI 1356;   Drug: sitagliptin
11 Active, not recruiting Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Glimepiride
12 Active, not recruiting Randomized, db, Placebo-controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Placebo
13 Completed Efficacy and Safety of B I1356 vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Placebo
14 Active, not recruiting Japanese P III vs Voglibose and Placebo
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: voglibose;   Drug: placebo
15 Recruiting Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin;   Drug: placebo
16 Recruiting Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin;   Drug: metformin
17 Recruiting Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Linagliptin
18 Recruiting Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Linagliptin;   Drug: Placebo
19 Completed Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Placebo;   Drug: Pioglitazone

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services